Progress in the Field of Aldehyde Dehydrogenase Inhibitors: Novel Imidazo[1,2-<i>a</i>]pyridines against the 1A Family
作者:Luca Quattrini、Edoardo Luigi Maria Gelardi、Giovanni Petrarolo、Giorgia Colombo、Davide Maria Ferraris、Francesca Picarazzi、Menico Rizzi、Silvia Garavaglia、Concettina La Motta
DOI:10.1021/acsmedchemlett.9b00686
日期:2020.5.14
the aldehyde dehydrogenase 1A family are commonly acknowledged as hallmarks of cancer stem cells, and their overexpression is significantly associated with poor prognosis in different types of malignancies. Accordingly, treatments targeting these enzymes may represent a successful strategy to fight cancer. In this work we describe a novel series of imidazo[1,2-a]pyridines, designed as aldehyde dehydrogenase
醛脱氢酶1A家族成员通常被认为是癌症干细胞的标志,它们的过表达与不同类型恶性肿瘤的不良预后显着相关。因此,靶向这些酶的治疗可能代表抗击癌症的成功策略。在这项工作中,我们描述了一系列新的咪唑并[1,2-a]吡啶,它们是通过先前开发的铅的基于结构的优化设计为醛脱氢酶抑制剂的。在体外评估了新化合物对ALDH1A家族的三种同工型的活性和选择性,并通过结晶和模型研究研究了它们与1A3同工型催化位点相互作用的能力。